Upload Avatar (500 x 500)
Guoliang Cui
gcui@ustc.edu.cn
Chinese, English, German
Anhui
University of Science and Technology of China
Basic Medical Sciences
  • 2001-2005 Bachelor's Degree: Shandong University
  • 2005-2010 Doctorate: Shanghai Institute of Nutrition, Chinese Academy of Sciences
  • 2010-2012 - GlaxoSmithKline China R&D Center - Research Fellow
  • 2012-2016 - Yale University, USA - Postdoctoral Researcher
  • 2016-2021 - German Cancer Research Center (DKFZ) - Tenure-track Researcher
  • 2021-2023 - German Cancer Research Center (DKFZ) - Permanent Researcher, Head of Division
  • 2023-2024 - Hefei Comprehensive National Science Center - Senior Researcher
  • 2024-present - University of Science and Technology of China - Professor
  • 2016: Helmholtz Young Investigator Award by Helmholtz Association
  • 2020: Georges-Köhler Award by German Society for Immunology
  • 2021: Lloyd J. Old STAR Award by Cancer Research Institute, New York
  • 2021: EMBO Young Investigator Program (EMBO YIP)
  • 2022: ERC Consolidator Award by European Research Council
  • 2024: National Distinguished Young Scholar
Metabolic mechanisms of T cell differentiation
Development of novel immunotherapeutic drug targets for cancer and infection
  • Serine enrichment in tumor promotes regulatory T cell accumulation through sphinganine., Sicong Ma, Roger Sandhoff, Xiu Luo, Fuwei Shang, Qiaozhen Shi, Zhaolong Li, Jingxia Wu, Yanan Ming, Frank Schwarz, Alaa Madi, Nina Weisshaar, Alessa Mieg, Marvin Hering, Xin Yan, Kerstin Mohr, Nora ten Bosch, Zhe Li, Gernot Poschet, Hans-Reimer Rodewald, Nina Papavasiliou, Xi Wang, Pu Gao & Guoliang Cui, 2024
  • The malate shuttle detoxifies ammonia in exhausted T cells by producing 2-ketoglutarate., Nina Weisshaar, Sicong Ma, Yanan Ming, Alaa Madi, Alessa Mieg, Marvin Hering, Ferdinand Zettl, Kerstin Mohr, Nora Ten Bosch, Diana Stichling, Michael Buettner, Gernot Poschet, Glynis Klinke, Michael Schulz, Nina Kunze-Rohrbach, Carolin Kerber, Isabel Madeleine Klein, Jingxia Wu, Xi Wang & Guoliang Cui, 2023
  • Rgs16 promotes antitumor CD8+ T cell exhaustion., Nina Weisshaar, Jingxia Wu, Yanan Ming, Alaa Madi, Agnes Hotz-Wagenblatt, Sicong Ma, Alessa Mieg, Marvin Hering, Ferdinand Zettl, Kerstin Mohr, Tilo Schlimbach, Nora Ten Bosch, Franziska Hertel, Lisann Müller, Hannah Byren, Mona Wang, Helena Borgers, Mareike Munz, Lukas Schmitt, Franciscus van der Hoeven, Ulrich Kloz, Rafael Carretero, Nikolai Schleußner, Rene-Filip Jackstadt, Ilse Hofmann & Guoliang Cui, 2022
  • Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors., Shihao Xu, Omkar Chaudhary, Patricia Rodríguez-Morales, Xiaoli Sun, Dan Chen, Roberta Zappasodi, Ziyan Xu, Antonio F. M. Pinto, April Williams, Isabell Schulze, Yagmur Farsakoglu, Siva Karthik Varanasi, Jun Siong Low, Wenxi Tang, Haiping Wang, Bryan McDonald, Victoria Tripple, Michael Downes, Ronald M. Evans, Nada A. Abumrad, Taha Merghoub, Jedd D. Wolchok, Maxim N. Shokhirev, Ping-Chih Ho, Joseph L. Witztum, Brinda Emu, Guoliang Cui & Susan M. Kaech, 2021
  • Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness., Jingxia Wu, Sicong Ma, Roger Sandhoff, Yanan Ming, Agnes Hotz-Wagenblatt, Vincent Timmerman, Nathalie Bonello-Palot, Beate Schlotter-Weigel, Michaela Auer-Grumbach, Pavel Seeman, Wolfgang N. Löscher, Markus Reindl, Florian Weiss, Eric Mah, Nina Weisshaar, Alaa Madi, Kerstin Mohr, Tilo Schlimbach, Rubí M. H. Velasco Cárdenas, Jonas Koeppel, Florian Grünschläger, Lisann Müller, Maren Baumeister, Britta Brügger, Michael Schmitt, Guido Wabnitz, Yvonne Samstag & Guoliang Cui, 2019
T Cells Metabolism Differentiation Cancer Infection Immunotherapy Drug Targets Gene Knockout Mouse Models Biomarkers

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.